Dietary Supplement
Gelsectan
Gelsectan is a dietary supplement with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(1)
Other(1)
Detailed Status
Recruiting2
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting250%
withdrawn125%
unknown125%
Recent Activity
2 active trials
Showing 4 of 4
recruitingnot_applicable
Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
NCT07000383
recruitingnot_applicable
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NCT06681012
withdrawnnot_applicable
GELSECTAN® and Covert Hepatic Encephalopathy
NCT05189834
unknown
Effect of Gelsectan® in the Treatment of Low Anterior Resection Syndrome
NCT06162143
Clinical Trials (4)
Showing 4 of 4 trials
NCT07000383Not Applicable
Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
NCT06681012Not Applicable
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NCT05189834Not Applicable
GELSECTAN® and Covert Hepatic Encephalopathy
NCT06162143
Effect of Gelsectan® in the Treatment of Low Anterior Resection Syndrome
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4